1. Home
  2. KZIA vs JTAI Comparison

KZIA vs JTAI Comparison

Compare KZIA & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • JTAI
  • Stock Information
  • Founded
  • KZIA 1994
  • JTAI 2018
  • Country
  • KZIA Australia
  • JTAI United States
  • Employees
  • KZIA N/A
  • JTAI N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • JTAI Blank Checks
  • Sector
  • KZIA Health Care
  • JTAI Finance
  • Exchange
  • KZIA Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • KZIA 6.0M
  • JTAI 7.1M
  • IPO Year
  • KZIA 1999
  • JTAI N/A
  • Fundamental
  • Price
  • KZIA $0.88
  • JTAI $6.59
  • Analyst Decision
  • KZIA Strong Buy
  • JTAI
  • Analyst Count
  • KZIA 2
  • JTAI 0
  • Target Price
  • KZIA $11.50
  • JTAI N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • JTAI 13.3M
  • Earning Date
  • KZIA 03-26-2025
  • JTAI 03-31-2025
  • Dividend Yield
  • KZIA N/A
  • JTAI N/A
  • EPS Growth
  • KZIA N/A
  • JTAI N/A
  • EPS
  • KZIA N/A
  • JTAI N/A
  • Revenue
  • KZIA $1,655,324.00
  • JTAI $15,028,926.00
  • Revenue This Year
  • KZIA N/A
  • JTAI $21.49
  • Revenue Next Year
  • KZIA N/A
  • JTAI $10.05
  • P/E Ratio
  • KZIA N/A
  • JTAI N/A
  • Revenue Growth
  • KZIA 248000.00
  • JTAI 46.66
  • 52 Week Low
  • KZIA $0.85
  • JTAI $2.30
  • 52 Week High
  • KZIA $15.80
  • JTAI $315.00
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 29.00
  • JTAI 58.27
  • Support Level
  • KZIA $0.90
  • JTAI $3.90
  • Resistance Level
  • KZIA $1.60
  • JTAI $11.77
  • Average True Range (ATR)
  • KZIA 0.14
  • JTAI 1.29
  • MACD
  • KZIA 0.02
  • JTAI 0.65
  • Stochastic Oscillator
  • KZIA 4.00
  • JTAI 45.30

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: